Tsunada S, Fujimoto K, Gotoh Y, Sakai T, Kang M, Sakata T, Granger D N, Tso P
Department of Internal Medicine, Saga Medical School, Nabeshima, Japan.
Gastroenterology. 1994 Nov;107(5):1297-304. doi: 10.1016/0016-5085(94)90530-4.
BACKGROUND/AIMS: Previously, we showed that an elevated production of histamine promotes the healing of injured intestinal mucosa after ischemia-reperfusion. The aim of the present study was to determine whether histamine-mediated repair of the intestinal mucosa after ischemia-reperfusion involves the engagement of H1 or H2 receptors.
The superior mesenteric artery was occluded for 15 minutes followed by reperfusion, and H1- or H2-receptor antagonists were infused intraduodenally. After ischemia-reperfusion, ornithine decarboxylase activity in the jejunal mucosa and lipid transport to mesenteric lymph were examined.
In jejunal mucosa, ornithine decarboxylase activity markedly increased at 6 hours after reperfusion and remained elevated at 48 hours. The ischemia-reperfusion-induced increase in ornithine decarboxylase activity was attenuated (in a dose-dependent manner) by an H1-receptor antagonist (chlorpheniramine maleate) but not by an H2 antagonist (cimetidine). Intraperitoneal injection of an H3 antagonist (thioperamide) increased histamine output in mesenteric lymph and stimulated intestinal ornithine decarboxylase activity. Transport of dietary lipid into mesenteric lymph was depressed 24 hours after an ischemic insult, yet it returned to the normal level 48 hours after ischemia-reperfusion. The recovery of the lipid transport normally observed at 48 hours after ischemia-reperfusion was attenuated by the H1 antagonist.
The beneficial effects of histamine on the repair of intestinal mucosa after ischemia-reperfusion results from the engagement and activation of the H1 receptor.
背景/目的:此前,我们发现组胺产生增加可促进缺血再灌注后受损肠黏膜的愈合。本研究旨在确定缺血再灌注后组胺介导的肠黏膜修复是否涉及H1或H2受体的参与。
肠系膜上动脉闭塞15分钟后再灌注,并经十二指肠内注入H1或H2受体拮抗剂。缺血再灌注后,检测空肠黏膜中鸟氨酸脱羧酶活性以及脂质向肠系膜淋巴的转运情况。
在空肠黏膜中,再灌注后6小时鸟氨酸脱羧酶活性显著增加,并在48小时时仍保持升高。H1受体拮抗剂(马来酸氯苯那敏)可(以剂量依赖方式)减弱缺血再灌注诱导的鸟氨酸脱羧酶活性增加,而H2拮抗剂(西咪替丁)则无此作用。腹腔注射H3拮抗剂(硫代哌啶)可增加肠系膜淋巴中的组胺输出,并刺激肠道鸟氨酸脱羧酶活性。缺血损伤后24小时,膳食脂质向肠系膜淋巴的转运受到抑制,但在缺血再灌注后48小时恢复至正常水平。缺血再灌注后48小时通常观察到的脂质转运恢复被H1拮抗剂减弱。
组胺对缺血再灌注后肠黏膜修复的有益作用源于H1受体的参与和激活。